Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Alice R. Knoedler"'
Autor:
Elizabeth Stark, Richard Amdur, Alice R. Knoedler, Patricia Vázquez Rodríguez, Neelima Denduluri, Rebecca Kaltman, Sarit T. Kipnis, Tara Biagi, Nicole Casasanta, Amy Marino, Claudine Isaacs, Laura Linville, Shawn Lipinski, Allision McHenry
Publikováno v:
Clinical breast cancer. 20(2)
Oncotype DX (ODX) is a genomic assay of tumor tissue that is utilized to predict the likelihood of recurrence and benefit of chemotherapy in breast cancer patients. Five to 10% of breast cancers are hereditary, and hereditary syndromes may not be unc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cea1a828a2429b01a975fd8f209d1cd
https://pubmed.ncbi.nlm.nih.gov/31964593
https://pubmed.ncbi.nlm.nih.gov/31964593
Autor:
Aiwu R. He, Matthew Blackburn, Subha Madhavan, Jeevan Puthiamadathil, Bradley Scott Colton, Alice R. Knoedler, Geoffrey T. Gibney, Anas Belouali, Mahsa Mohebtash, Ghassan Al-Shbool, William James Kelly, Neil J. Shah, Michael T. Serzan, Stephen V. Liu, Sebastian Ochoa, Chul Kim, Michael J. Pishvaian, Michael R. Cook, Michael B. Atkins
Publikováno v:
Cancer Research. 79:3230-3230
Background: Immune checkpoint inhibitors (ICIs) have become standard of care for many malignancies. However, patients (pts) with human immunodeficiency virus (HIV), hepatitis B (HBV), and hepatitis C (HCV) were excluded from many clinical trials. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9af9e424be13d6a6872bc2566f5077e8
https://doi.org/10.1158/1538-7445.am2019-3230
https://doi.org/10.1158/1538-7445.am2019-3230
Autor:
Subha Madhavan, Geoffrey T. Gibney, M. Janni, Neil J. Shah, J. Puthiamadathil, Michael T. Serzan, Anas Belouali, Alice R. Knoedler, B. Ma, Michael B. Atkins, S. OchoaGonzaelz, William James Kelly, Matthew Blackburn
Publikováno v:
Annals of Oncology. 29:viii433-viii434
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87a1f3841464b0043bfc7cfb2872084d
https://doi.org/10.1093/annonc/mdy288.093
https://doi.org/10.1093/annonc/mdy288.093
Autor:
Alice R Knoedler, William J Kelly, Sebastian Ochoa Gonzalez, Michael B. Atkins, Geoffrey T. Gibney, Megan M Janni, Matthew Blackburn, Subha Madhavan, Michael T Serzan, Stephen V. Liu, Bradley S Colton, Jeevan Puthiamadathil, Neil J. Shah, Pallavi Kumar, Anas Belouali, Barbara T Ma
Publikováno v:
Journal of Clinical Oncology. 36:e15074-e15074
e15074Background: ICI use is associated with immune-related adverse events (irAEs). Most irAEs occur early (within 3 months), but data regarding late toxicities is not well reported. Methods: Patie...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91e0cd586a1faf3388f0525e8d9b6ea4
https://doi.org/10.1200/jco.2018.36.15_suppl.e15074
https://doi.org/10.1200/jco.2018.36.15_suppl.e15074